MURAT ÇINARSOY
Professional Experience: Haematologist for 10 years, physician for 25 years.
Date of Birth:5.11.1971
Marital Status: Married
Child:1, a girl
Formal Education: Samsun Sami Kefeli Primary School
Samsun Anatolian High School
Graduated from Faculty of Medicine: Ankara University Faculty of Medicine
Internal Medicine Specialisation: Ankara Numune Training and Research Hospital ,
II. Internal Medicine Clinic
Clinic Chief : Dr Erdal Eskioglu
Haematology Subspecialisation: Health Sciences University Dr Abdurrahman Yurtaslan
Ankara Oncology Training and Research Hospital
Clinic Chief: Dr Fevzi Altuntas
Foreign Language:English
Hobbies:Reading, Cinema
PUBLICATIONS:
1. Diagnosis of large granular lymphocytic leukemia in a patient previously treated for acute myeloblastic leukemia. .Bozdag SC, Namdaroglu S, Kayikci O, Kaygusuz G, Demiriz I, Cinarsoy M, Tekgunduz E, Altuntas F Hematol Rep. 2013 Dec 23;5(4):e14. doi: 10.4081/hr.2013.e14. PMID: 24416499; PMCID: PMC3883061.
2. A feasible shortcut for the mobilization outcome: Steady state CD34 positive hematopoietic stem cells. Yüksel MK, Tekgündüz E, Sönmez C, Topcuoglu P, Yurtcu A, Demiriz I, Tetik A, Kayıkçı O, Cınarsoy M, Altuntaş F. Transfus Apher Sci. 2012 Aug;47(1):67-75. doi: 10.1016/j.transci.2012.05.003. Epub 2012 May 31. PMID: 22658279.
3.Ahmet Kürsad Güneş , Murat Çınarsoy. Erken Evre Klasik Hodgkin Lenfoma Vakalarında Tedavi Yanıtlarının Değerlendirilmesi.Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi.Yıl:2021, Cilt:8,Sayı:3,172-178,28.12.2021.
BOOK CHAPTERS:
1.Current Approaches in Haematology. Polystemi Vera: Diagnosis and Treatment.
Akademisyen Publishing House.2019.ISBN Number :9786052583791.
2.2019 Update in Multiple Myeloma and Plasma Cell Neoplasms. Chapter 8: Diagnosis in
Plasma Cell Neoplasms.Akademisyen Publishing House.ISBN Number:9786052585597
ABSTRACTS IN THE AMERICAN SOCIETY OF HAEMATOLOGY (ASH) CONGRESS
1.LONG ACTING ZOLEDRONIC ACID TREATMENT FOR VERTEBRAL FRACTURE PREVENTION IN MULTIPL MYELOMA PATIENTS WITH OSTEOPOROSIS. Murat Cinarsoy.Ahmet Kursad Gunes,Hılmı Erdem Gozden. Blood.Volume 132, Supplement 1 , 29 November 2018 ,Page 1954. https:doi.org/10.1182/blood-2018-99-111133
2.CASE REPORT:CHRONİC MYELOİD LEUKEMİA TREATMENT IN A HEMODIALYSIS PATIENT. Murat Çınarsoy,Ahmet Kursad Gunes , Hilmi Erdem Gozden. Blood. Volume 132, Supplement 1 , 29 November 2018 ,Page 5456.
3.EFFECTIVENESS OF DEFIBROTIDE IN THE PREVENTION OF VOD AMONG PATIENTS RECEIVING ALLOGENEIC HEMATOPOETIC CELL TRANSPLANTATION : A RETROSPECTIVE SINGLE CENTER EXPERIENCE . Emre Tekgunduz, MD, Seval Akpinar, Sinem Civriz Bozdag, MD, Aysegul Tetik, Serife Kocubaba, Murat Cinarsoy, Gamze Durgun, Sinem Namdaroglu, Omür Kayikci, Bilge Ugur, Itir Sirinoglu Demiriz, Fevzi Altuntas. Blood (2012) 120 (21): 4508.https://doi.org/10.1182/blood-2018-99-111465
EUROPEAN HEMATOLOGY ASSOCIATION (EHA) KONGRESİNDE YER ALAN POSTERLER
1.EHA-1576 POLYCYTHEMIA VERA: A DIAGNOSTIC CHALLENGE. Ahmet Kursad Gunes , Murat Cinarsoy , Hilmi Erdem Gozden.
2.PB2048 ACUTE IRON OVERLOAD WITH IRON CORBOXYMALTOSE : A CAE REPORT. Çınarsoy M. Güneş A.K ,Gözden H.E.HemaSphere 3(S1):p 924, June 2019. DOI: 10.1097/01.HS9.0000566680.34557.d3
ABSTRACTS IN THE TURKISH HAEMATOLOGY SOCIETY (THD) CONGRESS
1.CAN LONG-ACTING ZOLEDRONIC ACID BE A CHOICE IN PATIENTS WITH MULTIPLE MYELOMA AND OSTEOPOROSIS? Murat Çınarsoy , Ahmet Kürşad Güneş , Hilmi Erdem Gözden , Tufan Çiftçi , Esra Nur Yetkin
2. BONE MARROW TRANSPLANTATION IN SYRIAN FOREIGNERS: LEGAL DIFFICULTIES AND SOLUTION SUGGESTIONS . Murat Çınarsoy , Hilmi Erdem Gözden, Ahmet Kürşad Güneş
3. CASE REPORT OF OVERDOSE OF IRON CARBOXYMALTOSE . Murat Çınarsoy , Ahmet Kürşad Güneş , Hilmi Erdem Gözden , Esra Nur Yetkin
4. IS IT A PRACTICAL PRACTICE TO SCREEN EVERY PATIENT WITH ELEVATED HAEMOGLOBIN OR HAEMATOCRIT FOR POLYSTYMA VERA? Ahmet Kürşad Güneş, Hilmi Erdem Gözden, Murat Çınarsoy
5. A CASE OF HODGKIN LYMPHOMA PRESENTING WITH QUADRIPLEGIA. Ahmet Kürşad Güneş, Hilmi Erdem Gözden, Ali İhsan Gemici, Murat Çınarsoy
6. MANTLE CELL LYMPHOMA WITH ORBITAL INVOLVEMENT: CASE REPORT . Ahmet Kürşad Güneş, Hilmi Erdem Gözden, Ali İhsan Gemici, Murat Çınarsoy
7. TREATMENT OF CHRONIC MYELOID LEUKAEMIA IN A PATIENT ON A REGULAR HAEMODIALYSIS PROGRAMME: CASE REPORT Murat Çınarsoy1 , Ahmet Kürşad Güneş1 , Hilmi Erdem Gözden2 , Tufan Çiftçi3 , Ebru Tunçez1
8. INVESTIGATION OF THE EFFECT OF CELL SUBTYPE ON RESPONSES TO HYPERCVAD INDUCTION IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA PATIENTS. Murat Çınarsoy, Ayşegül Tetik, Mehmet Özen, Ali İrfan Emre Tekgündüz, Fevzi Altuntaş. 41.Ulusal Hematoloji Kongresi Bildiri Özeti Kitabı.2015.Sayfa.133.
9. THE INCIDENCE OF ENDOCRINE COMPLICATIONS IN BETA THALASSAEMIA MAJOR PATIENTS AND ITS RELATIONSHIP WITH FERRITIN LEVEL. Murat Çınarsoy, Aliihsan Gemici, Müge Özcan. 41.Ulusal Hematoloji Kongresi Bildiri Özeti Kitabı.Sayfa 197.
10. A CASE USING PROTHROMBIN COMPLEX CONCENTRATE IN THE TREATMENT OF BLEEDING COMPLICATIONS DUE TO RIFLOXABAN USE. Ali İhsan Gemici, Murat Çınarsoy. 41.Ulusal Hematoloji Kongresi Bildiri Özeti Kitabı.Sayfa 210.
11. A CASE OF RICHTER TRANSFORMATION USING A COMBINATION OF RITUXIMAB, IBRUTINIB AND BORTEZOMIB. Murat Çınarsoy, Aliihsan Gemici, Itır Demiriz, Ali İrfan Emre Tekgündüz, Fevzi Altuntaş. 41.Ulusal Hematoloji Kongresi Bildiri Özeti Kitabı.Sayfa 241.
12. A CASE REPORT OF LOSS OF RESPONSE TO ELTROMBOPAG FOLLOWED BY A COMPLETE RESPONSE WITH ELTROMBOPAG AGAIN FOLLOWING RITUXIMAB USE. Murat Çınarsoy, Aliihsan Gemici. 41.Ulusal Hematoloji Kongresi Bildiri Özeti Kitabı.Sayfa 310.
13. THE USE OF BENDAMUSTINE AND RİTUXİMAB COMBINATION IN THE FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA CASES IN WHOM CHLORAMBUCIL IS NOT AVAILABLE. Murat Çınarsoy, Aliihsan Gemici. 41.Ulusal Hematoloji Kongresi Bildiri Özeti Kitabı.Sayfa 318
ORAL PRESENTATIONS
1.WHAT IS THE CURRENT TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA? Gaziantep II. Zeugma Hematoloji Günleri 8 Haziran 2024.
2COMPARISON OF DANA FARBER AND HYPERCVAD PROTOCOLS IN ACUTE LENFOBLASTIC LEUKEMIA PATIENTS UNDER 40 YEARS OF AGES.
41st National Haematology Congress.
1. CHANGES IN THE DIAGNOSTIC CRITERIA FOR POLYSTYMA VERA AND DAILY IMPACT ON PRACTICE .
44th National Haematology Congress.